Estimation of Pentrexin-3 Levels in GCF and Saliva of Patients With Periodontal Disease
Assessment of Pentraxin-3 Levels in Gingival Crevicular Fluid and Saliva in Periodontal Health and Disease
1 other identifier
observational
40
0 countries
N/A
Brief Summary
Subjects were selected from the outpatient clinic, Department of Oral Medicine and Periodontology, Faculty of Oral and Dental Medicine, Cairo University. Ten healthy control subjects presented with clinically healthy periodontium. Ten patients who had plaque induced gingivitis. Ten patients who had generalized chronic periodontitis. Ten patients who had generalised aggressive periodontitis. Pentraxin-3 levels were evaluated in GCF and saliva of all subjects included in this study with ELISA technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedFirst Submitted
Initial submission to the registry
April 21, 2017
CompletedFirst Posted
Study publicly available on registry
April 25, 2017
CompletedJune 15, 2017
June 1, 2017
1.2 years
April 21, 2017
June 14, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
GCF and salivary pentraxin-3 levels
levels of pentraxin-3 in GCF and saliva
baseline
Secondary Outcomes (4)
plaque index
baseline
gingival index
baseline
probing pocket depth
baseline
clinical attachment level
baseline
Study Arms (4)
healthy control
Ten healthy control subjects presented with clinically healthy periodontium. Control subjects had to meet the following criteria for inclusion: probing depth less than 3mm, no clinical attachment loss, no bleeding on probing, with Gingival and Plaque index 0-1.
plaque induced gingivitis
Ten patients who had plaque induced gingivitis characterized by the presence of any of the following clinical signs: redness and edema of the gingival tissue, bleeding upon provocation, changes in contour and consistency, presence of calculus and/or plaque, with no clinical attachment loss nor radiographic evidence of bone loss.
chronic periodontitis
Ten chronic moderate to severe periodontitis patients selected according to the criteria currently adopted by Armitage 1999. Moderate destruction is generally characterized by periodontal probing depths up to 6 mm with clinical attachment loss of up to 4 mm. Advanced destruction is generally characterized by periodontal probing depths greater than 6 mm with attachment loss greater than 4 mm. Radiographic evidence of bone loss is apparent, Increased tooth mobility may be present.
aggressive periodontitis
Ten patients suffering generalized aggressive periodontitis, patients were less than 35 years of age and had generalized interproximal attachment loss affecting at least 3 permanent teeth other than the first molars and incisors with at least one site each with PD and CAL \>5 mm, Attachment loss occurs in pronounced episodic periods of destruction, and there is familial aggregation (subjects were asked if they had at least one other member of the family presenting or with a history of periodontal diseases).
Eligibility Criteria
Patients from the outpatient clinic, Department of Oral Medicine and Periodontology, Faculty of Oral and Dental Medicine, Cairo University suffering from diffrent periodontal diseases.
You may qualify if:
- patients with plaque induced gingivitis
- patients with chronic periodontitis
- patients with aggressive periodontitis
You may not qualify if:
- Patients with any systemic disease according to Cornell medical index (1968).
- Patients taking any medications or antibiotics in the last 3 months.
- Current or former smoker patients.
- Pregnant females.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Related Publications (3)
Fujita Y, Ito H, Sekino S, Numabe Y. Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis. Odontology. 2012 Jul;100(2):215-21. doi: 10.1007/s10266-011-0042-1. Epub 2011 Sep 20.
PMID: 21932007RESULTLakshmanan R, Jayakumar ND, Sankari M, Padmalatha O, Varghese S. Estimation of pentraxin-3 levels in the gingival tissues of chronic and aggressive periodontitis participants: an in vivo study. J Periodontol. 2014 Feb;85(2):290-7. doi: 10.1902/jop.2013.120718. Epub 2013 May 23.
PMID: 23701480RESULTGumus P, Nizam N, Nalbantsoy A, Ozcaka O, Buduneli N. Saliva and serum levels of pentraxin-3 and interleukin-1beta in generalized aggressive or chronic periodontitis. J Periodontol. 2014 Mar;85(3):e40-6. doi: 10.1902/jop.2013.130281. Epub 2013 Aug 16.
PMID: 23952075RESULT
Biospecimen
salivary and GCF samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Engy Ahmed, M.D.
Associate Professor of Oral Medicine & Periodontology, faculty of Oral and Dental Medicine, Cairo University
- PRINCIPAL INVESTIGATOR
Yasmine Mansour, B.D.Sc
master candidate at faculty of dentistry cairo university
- STUDY CHAIR
Olfat Shaker
Professor of Medical Biochemistry, Faculty of Medicine, Cairo University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Oral Medicine and Periodontology, Faculty of Dentistry, Cairo University.
Study Record Dates
First Submitted
April 21, 2017
First Posted
April 25, 2017
Study Start
December 1, 2015
Primary Completion
February 1, 2017
Study Completion
April 1, 2017
Last Updated
June 15, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share